ITT to Participate in Gabelli & Company’s 27th Annual Pump, Valve and Water Systems Symposium
ITT Reports 2016 Fourth-Quarter and Full-Year Results, 2017 Guidance
Gabelli & Company’s 27th Annual Pump, Valve & Water Systems Symposium
Harris Corporation Reports Fiscal 2017 Second Quarter Results
Aeterna Zentaris Announces Plans to Pursue FDA Registration of Macrilen™
Phase II Study Supports Potential for Genentech’s Tecentriq® (Atezolizumab) Plus Avastin® (Bevacizumab) for People With Locally Advanced or Metastatic Renal Cell Carcinoma
Government regulation is a risk to companies.
These stalwarts look cheap, and they could benefit from a boost in business spending.
We saw a higher level of trading by our top managers in the most recent period.
We are placing ITT Industries ITT under review while we transfer analyst coverage.